Abstract
The intercellular adhesion molecule-1 (ICAM1) has been reported to function in multiple malignancies, but its effect on clear cell renal cell carcinoma (ccRCC) hasn’t been discussed yet. This study aimed to identify the potential role of ICAM1 in prognostic prediction and early diagnosis of ccRCC. ICAM1 expression was inspected by immunohistochemistry and correlated with clinicopathologic variables. Association between protein expression and cancer-specific survival (CSS) of ccRCC patients was evaluated and the value of area under the receiver operating characteristics (ROC) curve (AUC) was calculated to measure the protein’s diagnostic accuracy. ICAM1 was positively immunostained in 83.2 % of 173 ccRCC tissues, but negatively immunostained in all the para-cancerous normal epitheliums of renal tubules. High ICAM1 expression was significantly related to male sex (P = 0.00241), T3/T4 stage (P = 0.02249), non-N0M0 stage (P = 0.03797) and positive renal pelvis invasion (P = 0.04227). Kaplan–Meier survival analysis illustrated that high ICAM1 expression was significantly correlated to a decreased CSS (P = 0.00006). Multivariate Cox analysis indicated that ICAM1 was an independent predictor for CSS of patients (P = 0.00451). Furthermore, the AUC value of ICAM1 in diagnosing ccRCC was 0.916 (P < 0.00001). In conclusion, high ICAM1 expression on tumor cells indicates a poor outcome of patients and ICAM1 is likely to be an independent predictor for the prognosis of ccRCC. Moreover, ICAM1 has a high AUC value and may be a potential and useful diagnostic marker.
Similar content being viewed by others
References
Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M (1993) Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res 53(14):3343–3348 PMID: 7686816
Cambio AJ, Evans CP (2006) Management approaches to small renal tumours. BJU Int 97(3):456–460 PMID: 16469007
Chae EJ, Kim JK, Kim SH, Bae SJ, Cho KS (2005) Renal cell carcinoma: analysis of postoperative recurrence patterns. Radiology 234(1):189–196 Epub 2004 Nov 10. PMID: 15537838
Diamond MS, Staunton DE, Marlin SD, Springer TA (1991) Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65(6):961–971 PMID: 1675157
Escudier B (2012) Emerging immunotherapies for renal cell carcinoma. Ann Oncol 23(Suppl 8):viii35–viii40. doi:10.1093/annonc/mds261 PMID: 22918926
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, TARGET Study Group (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134 PMID: 17215530
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide in 2008. IARC CancerBase No. 10 [Internet] Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr/
Heicappell R, Podlinski J, Buszello H, Ackermann R (1994) Cell surface expression and serum levels of intercellular adhesion molecule-1 in renal cell carcinoma. Urol Res 22(1):9–15 PMID: 7915444
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O’Toole T, Lustgarten S, Moore L, Motzer RJ, Global ARCC Trial (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356(22):2271–2281 PMID: 17538086
Iwamoto H, Kanda Y, Sejima T, Osaki M, Okada F, Takenaka A (2014) Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol 44(1):53–58. doi:10.3892/ijo.2013.2169
Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844–847
Kurban G, Gedye C, Morales C, Yousef GM, Almatar A, Jewett MA (2013) Diagnosis and treatment of small renal masses: the role for molecular biology. Arch Esp Urol 66(5):505–516 PMID: 23793768
Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR (2012) Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Lung Cancer 77(1):176–182. doi:10.1016/j.lungcan.2012.03.001 Epub 2012 Mar 26. PMI D: 22456526
Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R (2009) 2009 Update on the classification of renal epithelial tumors in adults. Int J Urol 16(5):432–443. doi:10.1111/j.1442-2042.2009.02302.x Epub 2009 Apr 20. PMID: 19453547
Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y, Ohira M, Ishikawa T, Hirakawa-YS Chung K (2002) Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 9(3):511–514 PMID: 11956618
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124 PMID: 17215529
Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S (1990) Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 50(4):1271–1278 PMID: 1967552
Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, Kato Y, Yoshikawa K, Sowa M (1998) Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res 4(1):31–36 PMID: 9516949
Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166(5):1611–1623 PMID: 11586189
Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O (2012) Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10:55. doi:10.1186/1479-5876-10-55 PMID: 22440013
Robson CJ, Churchill BM, Anderson W (2002) The results of radical nephrectomy for renal cell carcinoma. 1969. J Urol 167(2 Pt 2):873–875 (discussion 876–877). PMID: 11905914
Sengupta S, Leibovich BC, Blute ML, Zincke H (2005) Surgery for metastatic renal cell cancer. World J Urol 23(3):155–160 PMID: 15988593
Springer TA, Dustin ML, Kishimoto TK, Marlin SD (1987) The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 5:223–252 PMID: 3109455
Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA (1988) Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52(6):925–933 PMID: 3349522
Tanabe K, Campbell SC, Alexander JP, Steinbach F, Edinger MG, Tubbs RR, Novick AC, Klein EA (1997) Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma. Urol Res 25(4):231–238 PMID: 9286030
Tomita Y, Nishiyama T, Watanabe H, Fujiwara M, Sato S (1990) Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses. Int J Cancer 46(6):1001–1006 PMID: 1979067
Usami Y, Ishida K, Sato S, Kishino M, Kiryu M, Ogawa Y, Okura M, Fukuda Y, Toyosawa S (2013) Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion. Int J Cancer 133(3):568–578. doi:10.1002/ijc.28066 Epub 2013 Mar 7. PMID: 23364881
Vasudev NS, Selby PJ, Banks RE (2012) Renal cancer biomarkers: the promise of personalized care. BMC Med 10:112. doi:10.1186/1741-7015-10-112 PMID: 230 16578
Yashiro M, Sunami T, Hirakawa K (2005) CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci 50(12):2224–2230 PMID: 1641 6166
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y, Yu W, Wu X, Ye J, Yang S, Lai Y, Li X (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol 44(6):669–677. doi:10.1007/s10735-013-9516-5 PMID: 23793934
Zimmermann K, Schmittel A, Steiner U, Asemissen AM, Knoedler M, Thiel E, Miller K, Keilholz U (2009) Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib. Oncology 76(5):350–354. doi:10.1159/000209961 PMID: 19321976
Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19(6):1649–1657 PMID:11250993
Acknowledgments
We would like to thank the staff in the Department of Pathology of Yijishan Hospital for their contributions in samples collecting. Thanks to the technological support of central laboratory of Yijishan Hospital, Wuhu, Anhui, China.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, X., Jiang, J., Ye, X. et al. Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma. J Mol Hist 45, 427–434 (2014). https://doi.org/10.1007/s10735-014-9568-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-014-9568-1